Process for the preparation of an orexin receptor antagonist

Details for Australian Patent Application No. 2009249306 (hide)

Owner Merck Frosst Canada Ltd. Merck Sharp & Dohme Corp.

Inventors Campeau, Louis-Charles; Quellet, Stephane G.; Mellon, Christophe; O'Shea, Paul; Hughes, Gregory; Moore, Jeffrey C.; Girardin-Rondeau, Melina; Gauvreau, Danny

Agent Spruson & Ferguson

Pub. Number AU-A-2009249306

PCT Pub. Number WO2009/143033

Priority 61/128,505 22.05.08 US

Filing date 18 May 2009

Wipo publication date 26 November 2009

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 233/96 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/143033 Priority application(s): WO2009/143033

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.; Merck Frosst Canada Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009249314-Efficient production of heterologous proteins using mannosyl transferase inhibitors

2009249276-Ethylene-tetrafluoroethylene phosphate composition